1. Home
  2. IMNM vs BBAR Comparison

IMNM vs BBAR Comparison

Compare IMNM & BBAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$19.53

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

BBAR

Banco BBVA Argentina S.A. ADS

N/A

Current Price

$12.58

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
BBAR
Founded
2006
1886
Country
United States
Argentina
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
IMNM
BBAR
Price
$19.53
$12.58
Analyst Decision
Strong Buy
Buy
Analyst Count
16
4
Target Price
★ $35.20
$24.50
AVG Volume (30 Days)
★ 1.3M
509.1K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
N/A
★ 3.04%
EPS Growth
★ 51.40
N/A
EPS
N/A
★ N/A
Revenue
★ $6,941,000.00
N/A
Revenue This Year
N/A
$55.31
Revenue Next Year
$18,747.97
$17.79
P/E Ratio
★ N/A
$26.78
Revenue Growth
N/A
★ N/A
52 Week Low
$13.53
$9.15
52 Week High
$30.06
$22.47

Technical Indicators

Market Signals
Indicator
IMNM
BBAR
Relative Strength Index (RSI) 30.12 36.12
Support Level $19.39 $12.34
Resistance Level $23.48 $17.05
Average True Range (ATR) 1.12 0.54
MACD -0.27 0.04
Stochastic Oscillator 13.81 24.10

Price Performance

Historical Comparison
IMNM
BBAR

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

Share on Social Networks: